Fractures and avascular necrosis before and after orthotopic liver transplantation: Long-term follow-up and predictive factors

Hepatology

Volumn 46, Issue 4, 2007, Pages 1198-1207

  Guichelaar, Maureen M J ^a   Schmoll, Jeffrey ^a   Malinchoc, Michael ^a   Hay, J Eileen ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; AZATHIOPRINE; BISPHOSPHONIC ACID DERIVATIVE; COLESTYRAMINE; CYCLOSPORIN A; GLUCOCORTICOID; INSULIN; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; URSODEOXYCHOLIC ACID;

ARTICLE; AVASCULAR NECROSIS; BONE DENSITY; BONE MASS; CHOLESTASIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FEMUR FRACTURE; FOLLOW UP; FRACTURE; GRAFT REJECTION; HUMAN; LIPID METABOLISM; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OSTEOPENIA; PELVIS FRACTURE; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RIB FRACTURE; VERTEBRA FRACTURE;

ADULT; BONE DISEASES, METABOLIC; CHOLANGITIS, SCLEROSING; FEMALE; FOLLOW-UP STUDIES; FRACTURES, BONE; GLUCOCORTICOIDS; HUMANS; INCIDENCE; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OSTEONECROSIS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 36348941894     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21805     Document Type: Article

References (38)

1. Leidig-Bruchner G, Hosch S, Dodidou P, Ritschel D, Conradt C, Klose C, et al. Frequency and predicrors of osteoporotic fracrures after cardiac or liver transplantation: a follow-up study. Lancet 2001;357:342-347.
2. Haagsma EB, Thijn CJP, Post JG, Slooff MJH, Gips CH. Bone disease after orrhoropic liver transplantation. J Hepatol 1988;6:94-100.
3. McDonald JA, Dunstan CR, Dilworth P, Sherbon K, Sheil AG, Evans RA, et al. Bone loss after liver transplantation. HEPATOLOGY 1991;14:613-619.
4. Porayko MK, Wiesner RH, Hay JE, Krom RA, Dickson ER, Beaver S, et al. Bone disease in liver transplant recipients: incidence, timing, and risk factors. Transplant Proc 1991;23:1462-1465.
5. Monegal A, Navasa M, Guanabens N, Peris P, Pons F, Marrinez de Osaba MJ, et al. Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics. Osteoporos Int 2001;12:484-492.
6. Navasa M, Monegal A, Guanabens N, Peris P, Rimola A, Munoz-Gomez J, et al. Bone fractures in liver transplant patients. Br J Rheumatol 1994;33:52-55.
7. Feller RB, McDonald JA, Sherbon KJ, McCaughan GW. Evidence of continuing bone recovery at a mean of 7 years after liver transplantation. Liver Transplant Surg 1999;5:407-413.
8. Giannini S, Nobile M, Ciuffreda M, Iemmolo RM, Dalle Carbonare L, Minicuci N, et al. Long-term persistence of low bone density in orthotopic liver transplantation. Osteoporos Int 2000;11:417-424.
9. Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME. Pathogenesis and natural history of osteonecrosis. Semin Arthtitis Rheum 2002;32:94-124.
10. Jones JP Jr. Fat embolism and osteonecrosis. Clin North Am 1985;16:595-633.
11. Mankin HF. Nontraumatic necrosis of bone (osteonecrosis). N Engl J Med 1993;326:1473-1479.
12. Weinstein RS, Nicholas RW, Manolagas SC. Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. J Clin Endocrinol Metab 2000;85:2907-2912.
13. Spencer JD, Brookes M. Avascular necrosis and the blood supply of the femoral head. Clin Orthop 1988;98-110.
14. Marston SB, Gillingham J, Bailey RF, Cheng EY. Osteonecrosis of the femoral head after solid organ transplantation. J Bone Joint Surg Am 2002;85-A:2145-2151.
15. Guichelaar MMJ, Kendall R, Schmoll, J, Malinchoc M, Hay JE. Bone mineral density before and after OLT: long-term follow-up and predictive factors. Liver Transpl 2006;12:1390-1402.
16. Wiesner RH, LaRusso NF. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 1980;79:200-206.
17. Dickson ER, Fleming CR, Ludwig J. Primary biliary cirrhosis. Prog Liver Dis 1979;6:487-502.
18. Dickson ER, LaRusso NF, Wiesner RH. Primary sclerosing cholangitis. HEPATOLOGY 1984;4(Suppl):S33-S35.
19. Karnofsky DA, Ableman WH, Craver LF. The use of the nitrogen mustards in the palliative trearmenr of carcinoma. Cancer 1948;1:634-656.
20. Kao PC, Heser DW. Simultaneous determination of 26-hydroxy and 1.25-dihydroxyvitamin D from a single sample of dual cartridge extracrion. Clin Chem 1984;30:56-61.
21. Woodhead JS. The measurement of circulating parathyroid hormone. Clin Biochem 1990;23:17-21.
22. World Health Organization. Assessment of Fracture Risk and Its Application to Screening for Postmenopausal Osteoporosis. Geneva, Switzerland: WHO Press; 1994. WHO Technical Report Series; no. 843.
23. Kim WR, Therneau RM, Benson JR, Kremers WK, Rosen CB, Gores GJ, et al. Death of the liver transplant waiting list: an analysis of competing risks. HEPATOLOGY 2006;43:345-351.
24. Satagopan JM, Ben-Porat M, Berwick M, Robson M, Kutler D, Auerbach AD. A note on competing risks in survival data analysis. Br J Cancer 2004;91:1229-1235.
25. SAS Institute. SAS User's Guide. Vol 1. Cary, NC: SAS Institute; 1989.
26. S-PLUS Version 7.0.6 for Unix [computer program]. Seattle, WA: S-Plus Insightful Corp.; 1988.
27. Hay JE, Malinchoc M, Dickson ER. A controlled trial of calcitonin therapy for the prevention of post-liver transplantation atraumatic fractures in patients with primary biliary cirrhosis and primary sclerosing cholangitis. J Hepatol 2001;34:292-298.
28. Diamond TH, Stiel D, Lunzer M, McDowall D, Eckstein RP, Posen S. Hepatic osteodystrophy: static and dynamic bone histomorphometry and serum bone Gla-protein in 80 patients with chronic liver disease. Gastroenterology 1989;96:213-221.
29. Guichelaar MM, Malinchoc M, Sibonga JD, Clarke BL, Hay JE. Bone histomorphometric changes after liver transplantation for chronic cholestatic liver disease. J Bone Miner Res 2003;18:2190-2199.
30. Vedi S, Greer S, Skingle SJ, Garrahan NJ, Ninkovic M, Alexander GA, et al. Mechanism of bone loss after liver transplantation: a histomorphometric analysis. J Bone Miner Res 1999;14:281-287.
31. Segal A, Baruch Y, Kramsky R, Raz B, Tamir A, Ish-Shalom S. Predominant factors associated with bone loss in livet transplant patients - after prolonged post-transplantation period. Clin Transpl 2003;17:13-19.
32. Monegal A, Navasa M, Guanabens N, Peris P, Pons F, Martinez de Osaba MJ, et al. Bone mass and mineral metabolism in liver transplant recipients treated with FK506 or cyclosporine A. Calcif Tissue Int 2001;68:83-86.
33. Katz IA, Takizawa M, Jaffe II, Stein B, Fallon MD, Epstein S. Comparison of the effects of FK506 and cyclosporine on bone mineral metabolism in the rat. A pilot study. Transplantation 1991;52:571-574.
34. Cvetkovic M, Mann GN, Romero DF, Liang XG, Ma Y, Jee WS, et al. The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo. Transplantation 1994;57:1231-1237.
35. Papagelopoulos PJ, Hay JE, Galanis EC, Morrey BF. Total joint arthroplasty in orrhotopic liver transplant recipients. J Arthroplasty 1996;11:889-892.
36. Strasser S, Sheil AG, Gallagher ND, Waugh R, McCaughan GW. Liver transplantation for primary sclerosing cholangitis versus primary biliary cirrhosis: a comparison of complications and outcome. J Gastroenterol Hepatol 1993;8:238-243.
37. Mankin HF. Nontraumatic necrosis of bone (osteonecrosis). N Engl J Med 1993;326:1473-1479.
38. Janes CH, Dickson ER, Okazaki R, Bonde S, McDonagh AF, Riggs BL. Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest 1995;95:2581-2586.